These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 312645)

  • 1. In vitro and in vivo effects of alpha-acetylenic DOPA and alpha-vinyl DOPA on aromatic L-amino acid decarboxylase.
    Ribéreau-Gayon G; Danzin C; Palfreyman MG; Aubry M; Wagner J; Metcalf BW; Jung MJ
    Biochem Pharmacol; 1979 Apr; 28(8):1331-5. PubMed ID: 312645
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation.
    Bender DA; Coulson WF
    J Neurochem; 1972 Dec; 19(12):2801-10. PubMed ID: 4652630
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease in liver aromatic L-amino-acid decarboxylase produced by chronic administration of L-dopa.
    Dairman W; Christenson JG; Udenfriend S
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2117-20. PubMed ID: 5289371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of catechol structure in the inhibitory effects of D-isomers of amino acids on the decarboxylation of L-5-hydroxytryptophan.
    Shikimi T; Inagaki C; Takaori S
    Experientia; 1978 Sep; 34(9):1188-9. PubMed ID: 309827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).
    Christenson JG; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):343-7. PubMed ID: 4536745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G; Da Prada M; Pletscher A
    J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids].
    Borri-Voltattorni C; Minelli A; Turano C
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):700-2. PubMed ID: 5147578
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.
    Carlsson A; Davis JN; Kehr W; Lindqvist M; Atack CV
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(2):153-68. PubMed ID: 4404948
    [No Abstract]   [Full Text] [Related]  

  • 9. Origin of 5-hydroxytryptophan and l-dopa accumulating in brain following decarboxylase inhibition.
    Bédard P; Carlsson A; Fuxe K; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):1-6. PubMed ID: 4252440
    [No Abstract]   [Full Text] [Related]  

  • 10. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and properties of a homogeneous aromatic L-amino acid decarboxylase from hog kidney.
    Christenson JG; Dairman W; Udenfriend S
    Arch Biochem Biophys; 1970 Nov; 141(1):356-67. PubMed ID: 4991409
    [No Abstract]   [Full Text] [Related]  

  • 12. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 13. Coenzyme--substrate adducts as inhibitors of mouse liver 3,4-dihydroxyphenylalanine decarboxylase.
    Rudd EA; Cunningham WC; Thanassi JW
    J Med Chem; 1979 Mar; 22(3):233-7. PubMed ID: 423204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5-hydroxytryptophan nephrotoxicity by alpha-difluoromethyl-dopa, an inhibitor or L-amino acid decarboxylase.
    Zbinden G; Brändle E
    Toxicol Lett; 1980 Feb; 5(2):125-9. PubMed ID: 6781106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time and dose influences on the behavioral effects of L-DOPA and 5-hydroxytryptophan after inhibition of extracerebral decarboxylase.
    Gronan RJ
    Pharmacol Biochem Behav; 1975; 3(2):161-6. PubMed ID: 1079949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambivalence on the multiplicity of mammalian aromatic L-amino acid decarboxylase.
    Ebadi M; Simonneaux V
    Adv Exp Med Biol; 1991; 294():115-25. PubMed ID: 1772061
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
    Bartholini G; Constantinidis J; Tissot R; Pletscher A
    Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 19. 4-imidazolyl-3-amino-2-butanone (McN-A-1293), a new specific inhibitor of histidine decarboxylase.
    Taylor RJ; Leinweber FJ; Braun GA
    Biochem Pharmacol; 1973 Sep; 22(18):2299-310. PubMed ID: 4733681
    [No Abstract]   [Full Text] [Related]  

  • 20. (S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
    Porter CC; Torchiana ML; Stone CA
    Life Sci I; 1972 Aug; 11(16):787-95. PubMed ID: 4540250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.